Searched for
XELJANZ
Why is PFE stock falling today despite beating Pfizer's earnings estimates? Key factors investors are watchingPFE stock today: Pfizer's stock dipped despite strong fourth-quarter earnings. Investors reacted to the company's modest 2026 outlook. Decl...- TrumpRx website 2025: direct-to-consumer prescription drug platform and Pfizer discount deal explainedPresident Donald Trump announced TrumpRx, a government-operated website launching early 2026 for discounted prescription drugs. Pfizer agre...
- Over 250 medicines to cost more from January 1 in the U.S; is your critical drug in the list? Check hereMore than 250 medications, including Paxlovid and cancer therapies, will see price increases in the United States beginning January 1, 2025.
- Zydus Cadila gets tentative USFDA nod for generic drugThe company has received tentative approval from the US Food and Drug Administration (USFDA) for the product which is the generic version o...
- Pfizer’s patent claim for Xeljanz dismissedThe base compound of the drug has been granted patents in India and Pfizer attempted to secure additional patents for the follow-up improve...
Load More